Importantly, these findings are consistent with the established involvement of RANKL/RANK signaling in the acquisition of these aggressive malignant features in other tumors, such as cancers of the mammary and prostate gland [12, 18, 20, 21, 25, 42, 50, 51]. This evidence concerns the gene TNFSF11 and cancer.